Home
>
National Drug Code (NDC)
>
INDOCIN
INDOCIN - 42211-101-11 - (indomethacin)
Drug Information of INDOCIN
| Product NDC: | 42211-101 |
| Proprietary Name: | INDOCIN |
| Non Proprietary Name: | indomethacin |
| Active Ingredient(s): | 25 mg/5mL & nbsp; indomethacin |
| Administration Route(s): | ORAL |
| Dosage Form(s): | SUSPENSION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of INDOCIN
| Product NDC: | 42211-101 |
| Labeler Name: | Iroko Pharmaceuticals, LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA018332 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19851010 |
Package Information of INDOCIN
| Package NDC: | 42211-101-11 |
| Package Description: | 1 BOTTLE in 1 CARTON (42211-101-11) > 237 mL in 1 BOTTLE |
NDC Information of INDOCIN
| NDC Code | 42211-101-11 |
| Proprietary Name | INDOCIN |
| Package Description | 1 BOTTLE in 1 CARTON (42211-101-11) > 237 mL in 1 BOTTLE |
| Product NDC | 42211-101 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | indomethacin |
| Dosage Form Name | SUSPENSION |
| Route Name | ORAL |
| Start Marketing Date | 19851010 |
| Marketing Category Name | NDA |
| Labeler Name | Iroko Pharmaceuticals, LLC |
| Substance Name | INDOMETHACIN |
| Strength Number | 25 |
| Strength Unit | mg/5mL |
| Pharmaceutical Classes | Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC] |
